Author: Gourdas Choudhuri
Publisher: Elsevier Health Sciences
ISBN: 8131239594
Category : Medical
Languages : en
Pages : 102
Book Description
ECAB Non-alcoholic Fatty Liver Disease - E-Book
ECAB Non-alcoholic Fatty Liver Disease - E-Book
Author: Gourdas Choudhuri
Publisher: Elsevier Health Sciences
ISBN: 8131239594
Category : Medical
Languages : en
Pages : 102
Book Description
ECAB Non-alcoholic Fatty Liver Disease - E-Book
Publisher: Elsevier Health Sciences
ISBN: 8131239594
Category : Medical
Languages : en
Pages : 102
Book Description
ECAB Non-alcoholic Fatty Liver Disease - E-Book
ECAB Recent Advances in Hepatology - E-Book
Author: Sanjiv Saigal
Publisher: Elsevier Health Sciences
ISBN: 8131239705
Category : Medical
Languages : en
Pages : 151
Book Description
ECAB Recent Advances in Hepatology - E-Book
Publisher: Elsevier Health Sciences
ISBN: 8131239705
Category : Medical
Languages : en
Pages : 151
Book Description
ECAB Recent Advances in Hepatology - E-Book
ECAB Clinical Hepatology - E-Book
Author: Deepak Amarapurkar
Publisher: Elsevier Health Sciences
ISBN: 8131239543
Category : Medical
Languages : en
Pages : 137
Book Description
ECAB Clinical Hepatology - E-Book
Publisher: Elsevier Health Sciences
ISBN: 8131239543
Category : Medical
Languages : en
Pages : 137
Book Description
ECAB Clinical Hepatology - E-Book
ECAB Health Impact of Probiotics: Vision & Opportunities - E-Book
Author: G Balakrish Nair
Publisher: Elsevier Health Sciences
ISBN: 8131239489
Category : Medical
Languages : en
Pages : 177
Book Description
ECAB Health Impact of Probiotics: Vision & Opportunities - E-Book
Publisher: Elsevier Health Sciences
ISBN: 8131239489
Category : Medical
Languages : en
Pages : 177
Book Description
ECAB Health Impact of Probiotics: Vision & Opportunities - E-Book
ECAB Cholestatic Liver Disease - E-Book
Author: Prabha Sawant
Publisher: Elsevier Health Sciences
ISBN: 8131239632
Category : Medical
Languages : en
Pages : 154
Book Description
ECAB Cholestatic Liver Disease - E-Book
Publisher: Elsevier Health Sciences
ISBN: 8131239632
Category : Medical
Languages : en
Pages : 154
Book Description
ECAB Cholestatic Liver Disease - E-Book
Non-Alcoholic Fatty Liver Disease - ECAB
Author: Sudeep Khanna
Publisher: Elsevier Health Sciences
ISBN: 8131231909
Category : Medical
Languages : en
Pages : 142
Book Description
Non-alcoholic fatty liver disease is a common cause of chronic liver disease, and its incidence is rising worldwide. Understanding its pathogenesis, biochemical parameters, histological grading and staging, and its management is a vital issue in today's clinical practice. It appears to be linked directly to the growing epidemic of obesity in adults as well as in children. Thus, in a sense, NAFLD is a self-inflicted liver disease, much like alcoholic liver disease. The exact causes responsible for the development of NAFLD have not been established yet. However, some researchers consider that cluster of disorders that increases the risk of developing heart disease, diabetes, and stroke may be the factor behind development of NAFLD. Most patients with NAFLD have no symptoms or signs of liver disease at the time of diagnosis. In these patients, abnormal liver function tests are often discovered incidentally. Non-alcoholic steatohepatitis (NASH) is that stage of the spectrum that involves fat accumulation (steatosis), inflammation (hepatitis), and scarring (fibrosis) in the liver. Those who have fatty liver or hepatic steatosis with non-specific inflammation as fatty liver with non-specific inflammation generally have a benign longterm prognosis, whereas those who have NASH can progress to cirrhosis. NASH-related cirrhosis may have similar prognosis as cirrhosis from other causes. Hepatocellular carcinoma (HCC) is part of the spectrum of NAFLD, and screening for HCC seems reasonable in patients who have NASH-related cirrhosis. No established treatment is available for NAFLD. Some empiric treatment strategies have been suggested. Presumably, weight loss through exercise and diet modification along with insulinsensitizing agents will help reverse fatty infiltration of the liver. Its incidence is reportedly on the rise the world over as well as in India. Realizing its significance, there is now greater understanding of its etiology, pathogenesis, and management. The efforts of Elsevier have been directed toward addressing these aspects. Elsevier has thus pooled its existing resources with those of the internationally acclaimed Gastroenterologists of India who have chosen to share their rich clinical knowledge, experience, and expertize to serve the practitioners and patient community.
Publisher: Elsevier Health Sciences
ISBN: 8131231909
Category : Medical
Languages : en
Pages : 142
Book Description
Non-alcoholic fatty liver disease is a common cause of chronic liver disease, and its incidence is rising worldwide. Understanding its pathogenesis, biochemical parameters, histological grading and staging, and its management is a vital issue in today's clinical practice. It appears to be linked directly to the growing epidemic of obesity in adults as well as in children. Thus, in a sense, NAFLD is a self-inflicted liver disease, much like alcoholic liver disease. The exact causes responsible for the development of NAFLD have not been established yet. However, some researchers consider that cluster of disorders that increases the risk of developing heart disease, diabetes, and stroke may be the factor behind development of NAFLD. Most patients with NAFLD have no symptoms or signs of liver disease at the time of diagnosis. In these patients, abnormal liver function tests are often discovered incidentally. Non-alcoholic steatohepatitis (NASH) is that stage of the spectrum that involves fat accumulation (steatosis), inflammation (hepatitis), and scarring (fibrosis) in the liver. Those who have fatty liver or hepatic steatosis with non-specific inflammation as fatty liver with non-specific inflammation generally have a benign longterm prognosis, whereas those who have NASH can progress to cirrhosis. NASH-related cirrhosis may have similar prognosis as cirrhosis from other causes. Hepatocellular carcinoma (HCC) is part of the spectrum of NAFLD, and screening for HCC seems reasonable in patients who have NASH-related cirrhosis. No established treatment is available for NAFLD. Some empiric treatment strategies have been suggested. Presumably, weight loss through exercise and diet modification along with insulinsensitizing agents will help reverse fatty infiltration of the liver. Its incidence is reportedly on the rise the world over as well as in India. Realizing its significance, there is now greater understanding of its etiology, pathogenesis, and management. The efforts of Elsevier have been directed toward addressing these aspects. Elsevier has thus pooled its existing resources with those of the internationally acclaimed Gastroenterologists of India who have chosen to share their rich clinical knowledge, experience, and expertize to serve the practitioners and patient community.
A Dictionary of Chemical Engineering
Author: Carl Schaschke
Publisher: Oxford University Press
ISBN: 0199651450
Category : Reference
Languages : en
Pages : 449
Book Description
This new dictionary provides a quick and authoritative point of reference for chemical engineering, covering areas such as materials, energy balances, reactions, and separations. It also includes relevant terms from the areas of chemistry, physics, mathematics, and biology.
Publisher: Oxford University Press
ISBN: 0199651450
Category : Reference
Languages : en
Pages : 449
Book Description
This new dictionary provides a quick and authoritative point of reference for chemical engineering, covering areas such as materials, energy balances, reactions, and separations. It also includes relevant terms from the areas of chemistry, physics, mathematics, and biology.
Incretin Based Therapies
Author: Sanjay Kalra
Publisher: JP Medical Ltd
ISBN: 9350256487
Category : Medical
Languages : en
Pages : 194
Book Description
Incretins are a group of gastrointestinal hormones that cause an increase in the amount of insulin released from cells in the pancreas after eating. Incretin based drugs are used to control blood sugar levels in the management of diabetes. This book is a concise guide to incretin based therapy. Beginning with an introduction to the history and physiology of incretins, the following sections examine the clinical pharmacology of GLP-1 Analogues and DPP-4 Inhibitors, the pleiotrophic effects of incretins and comparative pharmacology. Each section integrates science with practical therapeutic guidance for clinicians involved in the management of diabetes. The final chapter discusses the future of incretin therapies, including non-diabetic usage and combination therapy. Key Features Concise overview of incretin based therapy for the management of diabetes Guides clinicians step by step through the history and pharmacology of various molecules Integrates science with practical therapeutic guidance Includes chapter on the future of incretin therapy
Publisher: JP Medical Ltd
ISBN: 9350256487
Category : Medical
Languages : en
Pages : 194
Book Description
Incretins are a group of gastrointestinal hormones that cause an increase in the amount of insulin released from cells in the pancreas after eating. Incretin based drugs are used to control blood sugar levels in the management of diabetes. This book is a concise guide to incretin based therapy. Beginning with an introduction to the history and physiology of incretins, the following sections examine the clinical pharmacology of GLP-1 Analogues and DPP-4 Inhibitors, the pleiotrophic effects of incretins and comparative pharmacology. Each section integrates science with practical therapeutic guidance for clinicians involved in the management of diabetes. The final chapter discusses the future of incretin therapies, including non-diabetic usage and combination therapy. Key Features Concise overview of incretin based therapy for the management of diabetes Guides clinicians step by step through the history and pharmacology of various molecules Integrates science with practical therapeutic guidance Includes chapter on the future of incretin therapy
Activities of the House Committee on Government Reform
Author: United States. Congress. House. Committee on Government Reform
Publisher:
ISBN:
Category : Legislative oversight
Languages : en
Pages : 748
Book Description
Publisher:
ISBN:
Category : Legislative oversight
Languages : en
Pages : 748
Book Description
Advances in Diabetes Management
Author: Unnikrishnan AG
Publisher: JP Medical Ltd
ISBN: 9351529037
Category : Medical
Languages : en
Pages : 214
Book Description
Advances in Diabetes Management: A Case Compendium is a collection of cases involving various disorders and complications of diabetes. Divided into 29 chapters, each one features a case study on a particular aspect of diabetes followed by a review of evidence. This book includes cases of both type one and type two diabetes and associated conditions, from polycystic ovarian syndrome to neuropathy and life-threatening foot infections. Chapters on new insulin pumps and bariatric surgery highlight the latest advances in the management of diabetes. Drawing on the experience of expert diabetologists and enhanced by full colour images and illustrations throughout, Advances in Diabetes Management: A Case Compendium is a valuable reference helping clinicians and trainees remain up to date with developments in the field. Key Points Guide to the latest advances in the field of diabetes management Collection of cases with review of evidence Full colour images and illustrations throughout
Publisher: JP Medical Ltd
ISBN: 9351529037
Category : Medical
Languages : en
Pages : 214
Book Description
Advances in Diabetes Management: A Case Compendium is a collection of cases involving various disorders and complications of diabetes. Divided into 29 chapters, each one features a case study on a particular aspect of diabetes followed by a review of evidence. This book includes cases of both type one and type two diabetes and associated conditions, from polycystic ovarian syndrome to neuropathy and life-threatening foot infections. Chapters on new insulin pumps and bariatric surgery highlight the latest advances in the management of diabetes. Drawing on the experience of expert diabetologists and enhanced by full colour images and illustrations throughout, Advances in Diabetes Management: A Case Compendium is a valuable reference helping clinicians and trainees remain up to date with developments in the field. Key Points Guide to the latest advances in the field of diabetes management Collection of cases with review of evidence Full colour images and illustrations throughout